| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/06/2004 | US6759536 Genetic engineering; polyketides |
| 07/06/2004 | US6759532 Extraction of nucleotide sequences from fish; obtain fish semen, disrupt semen, incubate with alkaline solution, incubate with ethanol, precipate nucleotide sequences |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759516 Methods of identifying antigen gene sequences |
| 07/06/2004 | US6759513 Death domain containing receptors |
| 07/06/2004 | US6759485 Crosslinked acrylated unsaturated polyester yields degradation products non-toxic, metabolized and excreted by the human kidney; mechanical properties, i.e. compressive strength and modulus; low water absorption; grafting implants |
| 07/06/2004 | US6759245 Has modular cell culturing devices with flat-plate modules, flow of liquid medium and oxygenated fluid are separated by a gas-permeable, liquid-impermeable membrane, and the cells are grown attached to the liquid side of the membrane |
| 07/06/2004 | US6759244 Embryonic cells for use as tools in in vitro fertilization |
| 07/06/2004 | US6759243 High affinity TCR proteins and methods |
| 07/06/2004 | US6759242 Low oxygen culturing of neural crest stem cells and methods of use |
| 07/06/2004 | US6759241 Isolated from gram negative bacterial strains that contain at least one mutation in at least one of the htrb and msbb genes, used as a vaccine |
| 07/06/2004 | US6759239 Reduction of risk of rejection of allografts and xenografts and autoimmune diseases using the human suppressor cd8+cd28- t cells |
| 07/06/2004 | US6759237 Recombinant viral vectors useful for gene delivery |
| 07/06/2004 | US6759227 Caspase homologue |
| 07/06/2004 | US6759211 For cancer use in therapy |
| 07/06/2004 | US6759210 Compositions and methods for the treatment and diagnosis of cardiovascular disease using fehd545 as a target |
| 07/06/2004 | US6759201 Method of identifying a neural progenitor cell by evaluating expression of daedalos |
| 07/06/2004 | US6759194 Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 07/06/2004 | US6759043 Monoclonal antibodies having property of causing apoptosis |
| 07/06/2004 | US6759039 Culturing pancreatic stem cells having a specified, intermediate stage of development |
| 07/06/2004 | US6759038 Evaluating drug for prevention of cancer propagation; administer drug to vertebrate, monitor cancer propagation by fluoresence, compare to control, decrease in fluoresence indicates prevention of tumor propagation |
| 07/06/2004 | US6759037 Compositions and methods for treating diabetes |
| 07/06/2004 | US6759035 Method to prevent graft rejection using TGF-beta to induce T suppressor cells |
| 07/01/2004 | WO2004055206A1 Method for generating a genetically modified organism for screening active substances |
| 07/01/2004 | WO2004055186A1 Guanosine triphosphate-binding protein-coupled receptor |
| 07/01/2004 | WO2004055175A1 Method for selection of compounds which inhibit clonal cell growth and use thereof |
| 07/01/2004 | WO2004055174A1 Culture medium composition, culture method, and myoblasts obtained, and their uses |
| 07/01/2004 | WO2004055155A2 Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same |
| 07/01/2004 | WO2004055053A1 Tumor vaccine |
| 07/01/2004 | WO2004034984A3 Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
| 07/01/2004 | WO2004031371A3 Programmable scaffold and methods for making and using the same |
| 07/01/2004 | WO2004029200A3 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 07/01/2004 | WO2004027070A3 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 07/01/2004 | WO2004019884A3 Agents and methods for enhancing bone formation |
| 07/01/2004 | WO2004015394A3 Cancer diagnostics and prognostics |
| 07/01/2004 | WO2004015389A3 Methods of identifying compouds that modulate igg mediated mast cell activation |
| 07/01/2004 | WO2004013151A3 Campylobacter glycans and glycopeptides |
| 07/01/2004 | WO2004011601A3 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 07/01/2004 | WO2004003511A3 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 07/01/2004 | WO2004001001A3 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 07/01/2004 | WO2003104416A3 Spliceosome mediated rna trans-splicing in stem cells |
| 07/01/2004 | WO2003099996A3 Detection of secreted polypeptides |
| 07/01/2004 | WO2003098212A3 Method of isolating an endotehelial cell and method of donor specific crossmatching |
| 07/01/2004 | WO2003093438A3 Human adipocyte cell populations and methods for identifying modulators of same |
| 07/01/2004 | WO2003092716A3 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders |
| 07/01/2004 | WO2003085099A3 A process for the preparation of stem cells from human muscle tissue and adipose tissue, and stem cells obtainable by this process |
| 07/01/2004 | WO2003083075A3 Retrovirus-based genomic screening |
| 07/01/2004 | WO2003080798A3 Muscle cells and their use in cardiac repair |
| 07/01/2004 | WO2003080649A3 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
| 07/01/2004 | WO2003078600A3 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 07/01/2004 | WO2003042240A3 Polypeptides of pseudomonas aeruginosa |
| 07/01/2004 | WO2003030719A9 Methods and kits for use in selecting approaches to treating cancer |
| 07/01/2004 | WO2003021265A8 Genetic construct intracellular monitoring system |
| 07/01/2004 | WO2003012045A3 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 07/01/2004 | WO2003009814A3 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 07/01/2004 | WO2002099083A3 Gfats as modifiers of the p53 pathway and methods of use |
| 07/01/2004 | WO2002015846A3 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 07/01/2004 | US20040128715 Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof |
| 07/01/2004 | US20040128707 Animal model for pancreatic disorder associated with signal transduction; obesity prevention |
| 07/01/2004 | US20040128704 Using nucleotide sequences coding apoptosis interacting protein to transform and propagate plant cells; heterologous gene expression and control of nematode infection, dehiscence and stigma morphology |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127695 Plants toxic to coleopteran insects and Ctenocephalides Spp. |
| 07/01/2004 | US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 07/01/2004 | US20040127563 composition, comprising: unsaturated vegetable oil ester; adipate; and vegetable oil polyols stimulates bone growth; glyceride and water within the mammal is converted into glycerol, fatty acid, and protons |
| 07/01/2004 | US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell |
| 07/01/2004 | US20040127410 Circular permuteins of flt3 ligand |
| 07/01/2004 | US20040127406 acinar cells undergo a 3-4 fold expansion together with transdifferentiation into a modified cell phenotype (IP cells) showing characteristics of acinar cells and liver cells and are further transformed to insulin-producing cells |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040126885 Delivery vehicle for recombinant proteins |
| 07/01/2004 | US20040126881 Fibrinogen and thrombin protein matrix for culturing tissues for use in skin grafts and replacement; tissue engineering |
| 07/01/2004 | US20040126880 Using gamma radiation to inactivate, decrease and/or remove contaminants associated with functioning biological materials, biochemical entities and biologically active molecules and storing materials at room temperature |
| 07/01/2004 | US20040126879 Heart derived cells for cardiac repair |
| 07/01/2004 | US20040126878 Method for the preparation of immunologically inert amniotic membranes |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126869 Method of producing infectious reovirus |
| 07/01/2004 | US20040126863 Comprises amino acid sequences for use in identifying modulators for diagnosis and treatment of respiratory and diabetes-induced peripheral vascular diseases; mimetics |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126845 Nucleotide sequences comprising regulatory elements which simultaneously enhance the expression of a first RNA sequence and at the same time as suppress the expression of a second RNA sequences; gene expression inhibition |
| 07/01/2004 | US20040126839 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/01/2004 | US20040126801 Novel polynucleotides and encoded polypeptides |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126774 Correction of factor VIII genetic defects using spliceosome mediated RNA trans splicing |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126468 Food or edible material and beverages: processes, compositions, and products |
| 07/01/2004 | US20040126405 Three-dimensional; biocompatible polymer |
| 07/01/2004 | US20040126388 Measurement genome reproduction of virus; linked to reproter compound; high speed screening for Hepatitis virus |
| 07/01/2004 | US20040126386 Mutant proteins; induce immunology response; antitumor agents |
| 07/01/2004 | US20040126364 Antiinflammatory agents; genetic engineered interleukins; oral diseases |
| 07/01/2004 | US20040126363 Cd19-specific redirected immune cells |
| 07/01/2004 | US20040126362 Anticancer agents; leukemia ; therapy, prevent of metabolism diseases |
| 07/01/2004 | DE10261125A1 Preparing stem cells from pancreas, useful as transplants for treating type I diabetes, by converting pancreatic tissue to a suspension and cell selection, applicable to small biopsy samples |
| 07/01/2004 | DE10260431A1 Self-justifying immobilization of living cells on a silicon substrate, useful in preparation of sensors, by attaching mutually interacting molecules to surfaces of cells and substrate |
| 07/01/2004 | CA2509642A1 Culture medium composition, culture method, and myoblasts obtained, and their uses |
| 07/01/2004 | CA2509333A1 Method for generating a genetically modified organism for screening active substances |
| 07/01/2004 | CA2508880A1 Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same |
| 07/01/2004 | CA2501039A1 Method for selection of compounds which inhibit clonal cell growth and use thereof |
| 06/30/2004 | EP1433855A2 Plasmids suitable for il-2 expression |
| 06/30/2004 | EP1433844A2 Novel recombinant xylanases derived from anaerobic fungi, and the relevant sequences, expression vectors and hosts |
| 06/30/2004 | EP1433792A2 Human receptor proteins, related reagents and methods |
| 06/30/2004 | EP1433487A1 Method of bone regeneration |